Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Partial Response”

218 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 218 results

Post-approval studies (Phase 4)UnknownNCT03798119
What this trial is testing

TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR)

Who this might be right for
Hepatitis BFibrosis and Cirrhosis of Liver
Kaohsiung Medical University Chung-Ho Memorial Hospital 80
Testing effectiveness (Phase 2)Study completedNCT01684163
What this trial is testing

Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants

Who this might be right for
Major Depressive Disorder
Naurex, Inc, an affiliate of Allergan plc 369
Post-approval studies (Phase 4)UnknownNCT03499171
What this trial is testing

Citalopram for Reflux Hypersensitivity and Functional Heartburn

Who this might be right for
GERD
Universitaire Ziekenhuizen KU Leuven 100
Testing effectiveness (Phase 2)Study completedNCT01372410
What this trial is testing

A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 163
Testing effectiveness (Phase 2)Looking for participantsNCT07284420
What this trial is testing

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

Who this might be right for
AChR-Ab Seropositive Generalized Myasthenia GravisMyasthenia GravisMG+3 more
argenx 70
Testing effectiveness (Phase 2)Ended earlyNCT05781750
What this trial is testing

Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)

Who this might be right for
Lupus Nephritis
Kezar Life Sciences, Inc. 84
Large-scale testing (Phase 3)Active Not RecruitingNCT06060665
What this trial is testing

Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)

Who this might be right for
Primary Biliary Cholangitis
Gilead Sciences 90
Testing effectiveness (Phase 2)Looking for participantsNCT06238648
What this trial is testing

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPrimary Mediastinal Large B-Cell LymphomaTransformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Academic and Community Cancer Research United 120
Early research (Phase 1)Ended earlyNCT00857571
What this trial is testing

A Four-Way Cross-Over Study To Compare The Plasma Concentrations Of PF-02413873 After Oral Administration Of Several Doses As Suspension And As Tablets.

Who this might be right for
Healthy
Pfizer 12
Early research (Phase 1)Study completedNCT03561233
What this trial is testing

Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis

Who this might be right for
Systemic SclerosisGastroesophageal RefluxProton Pubm Inhibitor
Khon Kaen University 250
Testing effectiveness (Phase 2)Ended earlyNCT00446303
What this trial is testing

A Phase II Study of Maintenance With Azacitidine in MDS Patients

Who this might be right for
Leukemia, Myelocytic, AcuteMyelodysplastic Syndromes
Groupe Francophone des Myelodysplasies 39
Post-approval studies (Phase 4)UnknownNCT03767452
What this trial is testing

Additional Xiaflex® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete Response

Who this might be right for
Peyronie's Disease
Manhattan Medical Research Practice, PLLC 20
Testing effectiveness (Phase 2)Study completedNCT01005251
What this trial is testing

Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI

Who this might be right for
Gastroesophageal Reflux DiseaseHeartburnRegurgitation
AstraZeneca 661
Post-approval studies (Phase 4)Study completedNCT02078882
What this trial is testing

Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis

Who this might be right for
Primary Biliary Cirrhosis
Christopher Bowlus, MD 16
Testing effectiveness (Phase 2)WithdrawnNCT00085579
What this trial is testing

Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center
Not applicableEnded earlyNCT01794572
What this trial is testing

Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse

Who this might be right for
Multiple Myeloma in Relapse
Institut Cancerologie de l'Ouest 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT03830918
What this trial is testing

Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy

Who this might be right for
Advanced Malignant Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more
Jonsson Comprehensive Cancer Center 59
Not applicableStudy completedNCT00765752
What this trial is testing

Cortical GABA Concentrations in Insomnia

Who this might be right for
InsomniaMajor Depression
Yale University 23
Testing effectiveness (Phase 2)Study completedNCT01413568
What this trial is testing

Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in RemissionChronic Myelogenous Leukemia (CML)+5 more
Polyphor Ltd. 38
Testing effectiveness (Phase 2)WithdrawnNCT02653989
What this trial is testing

Efficacy and Safety Study of MDV9300 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Lymphoma, Large B-Cell, DiffusePrimary Mediastinal Large B-cell LymphomaTransformed Indolent Lymphoma
Medivation, Inc.
Load More Results